In lung cancer, we and other groups reported that activation of HGF/MET causes resistance to EGFR‐TKIs and ALK‐TKIs in EGFR‐mutated NSCLC and ALK‐rearranged NSCLC, respectively.15, 22. Here, MET is linked to lung carcinoma.